HALO logo
halo search icon
RMDA
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda

RMDA · Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda

5.03

EGP
-0.07 (-1.37%)
23/06/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

EGP10.06B

PE

24.80

EV/EBITDA

8.8

DIV Yield

0.9%

Payout Ratio

22%

MQV Rating

4Weak

As at 23/06/2026 12:00:00 AM

Price Chart

Description

Tenth of Ramadan Company for Pharmaceuticals Industries & Diagnostic Reagents S.A.E. engages in the manufacture and marketing of pharmaceutical products for human and veterinary use. It operates through Production and Selling of Pharmaceutical Products; and Manufacturing for Others segments. The firm product categories include anti-infective, anti-diabetic, respiratory, ophthalmology, gastro-intestinal tract, cardio-vascular, central nervous system, vitamins, and analgesics. The company was founded on January 15, 1986 and is headquartered in 6th of October City, Egypt.

  • All-Companies
  • All-Consensus
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO Dividend Growth

Key Fundamentals

EPS 3 yr Growth

16.20%

EBITDA Margin

25.30%

Operating Cashflow

-£44m

Free Cash Flow Return

-2.00%

ROIC

12.50%

Interest Coverage

1.90

Quick Ratio

0.80

Performance

52 weeks range

Low 3.02 - 5.38

Trade Value (12mth)

US$226,597.00

1 week

1.21%

1 month

-1.95%

YTD

55.25%

1 year

63.99%

All time high

5.38

Additional Data

Shares Outstanding (Fully Diluted)

2,015m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

02-Jun-26

Next Dividend Pay Date

04-Jun-26

Reporting Currency

EGP

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI)?
Halo FAQ
The current share price of Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) is EGP£5.03.
2
What is the 52-week high share price for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI)?
Halo FAQ
The 52-week high share price for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) is EGP£5.38.
3
What is the 52-week low share price for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI)?
Halo FAQ
The 52-week low share price for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) is EGP£3.02.
4
What is the dividend yield for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI)?
Halo FAQ
The current TTM dividend payout for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) is 0.90.
5
What was Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) last dividend payment?
Halo FAQ
The last dividend payment of Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) is EGP£0.03.
6
What is the franking level for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI)?
Halo FAQ
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) has a franking level of 0.00%.
7
In which sector is Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) classified?
Halo FAQ
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI)?
Halo FAQ
The current P/E ratio for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA:CAI) is 24.80.